Dr Preetesh Jain was previously trained in general medicine and medical oncology in India. Following his medical schooling for each he repeated all his clinical training in the US. Dr Jain has also completed a PhD in molecular medicine on “Th17-IL-17 axis in CLL” at Feinstein Institute for Medical Research, Manhasset, New York. Furthermore, He has undergone further training at University of Texas- Houston and MD Anderson Cancer Center since 2012. In 2020 Dr. Jain was welcomed into his current role as Assistant Professor within the department of Lymphoma and Myeloma. He is a clinical investigator and translational researcher focusing on mantle cell lymphoma and works with Dr Wang within the Mantle Cell Lymphoma group at MD Anderson.

Dr Jain has received multiple awards for his research in lymphoma and leukemia and has been an invited speaker at national and international conferences. He is an invited reviewer for articles in various journals and has published several research papers. He is the principal investigator on Phase III randomized MANGROVE study in MCL at MDACC, He has authored many articles in high-impact peer-reviewed journals such as the Blood, Blood advances, Lancet Oncology, Lancet Hematology, Clinical Cancer research, Journal of Clinical Oncology, American Journal of Hematology, and the British Journal of Hematology. His work has been cited several times by other investigators with an H-index of 35.